At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Smoking Cessation for Cervical Cancer Survivors in a Safety Net Healthcare System
In Brief
A clinical study evaluating Self-Help Materials, Nicotine Patch, and 4 other interventions for Cervical Cancer and 2 related conditions. Completed, enrolled 202 participants across 3 sites.
Detailed Summary
The goal of this research study is to compare a program called Motivation And Problem-Solving (MAPS) to the standard treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.
Study Details
Timeline
Interventions
Participants receive free self-help materials mailed at baseline, 6, and 12 months. and a referral to the Oklahoma Quitline.
Participants receive a 12-week supply of nicotine patch. Nicotine patch regime based on participant's self-reported smoking rate. Participants who smoke \>10 cigarettes/day receive 8 weeks of 21 mg, 2 week of 14 mg, and 2 week of 7 mg patches. Those who smoke \<10 cigarettes/day receive 8 weeks of 14 mg and 4 weeks of 7 mg patches.
REDCap will be used to collect all questionnaires data over the phone. Questionnaires done at baseline to randomize, then at 3, 6, 12, and 18 months.
Saliva test performed at 3, 6, 12, and 18 months.
6 telephone counseling sessions performed over 12 months. Sessions performed at baseline, 3, 6, 12, and 18 months. Sessions digitally recorded.
Participants receive a 12-week supply of nicotine lozenges. All participants receive 12 weeks of 2mg lozenges.